INCRELEX

Product Overview

About INCRELEX

INCRELEX is a medicine that contains the active ingredient MECASERMIN, which is used to treat growth failure in children with severe primary insulin-like growth factor-1 deficiency (IGFD). This condition is characterized by a lack of insulin-like growth factor-1 (IGF-1), which is essential for normal growth and development. INCRELEX helps to replace the missing IGF-1, promoting growth and development in children with this condition.

Key Benefits & Uses

• Treatment of growth failure in children with severe primary IGFD
• Promotes growth and development in children with IGF-1 deficiency
• Helps to improve height and weight in children with this condition

Active Ingredient & Action

MECASERMIN, the active ingredient in INCRELEX, works by binding to insulin-like growth factor-1 receptors, stimulating the growth and development of bones and other tissues. This helps to promote linear growth and increase height and weight in children with severe primary IGFD.

Important Notes

INCRELEX should only be used under the guidance of a healthcare professional and with regular monitoring of growth and development. Patients should follow the recommended dosage and administration instructions carefully, and report any adverse reactions or concerns to their healthcare provider. It is essential to note that INCRELEX is not a substitute for other treatments or therapies that may be prescribed for growth hormone deficiency or other related conditions.